29th week of 2019 patent applcation highlights part 8 |
Patent application number | Title | Published |
20190216704 | COMBINATIONS OF N-ACETYL CYSTEINE DERIVATIVES AND CRANBERRY POLYPHENOLS IN COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING PERIODONTAL DISEASES AND PERI-IMPLATITIS | 2019-07-18 |
20190216705 | HAIR CARE COMPOSITIONS COMPRISING THIOLACTIC ACID-BASED IONIC LIQUIDS OR THIOLACTIC ACID-BASED IONIC MIXTURES | 2019-07-18 |
20190216706 | AQUEOUS SURFACTANT COMPOSITIONS | 2019-07-18 |
20190216707 | COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH, COMPRISING PHYTOESTROGEN AS AN ACTIVE INGREDIENT | 2019-07-18 |
20190216708 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | 2019-07-18 |
20190216709 | PROTEIN HYDROLYSATES | 2019-07-18 |
20190216710 | ANHYDROUS POLYSACCHARIDE FILMS | 2019-07-18 |
20190216711 | COSMETIC COMPOSITION FOR EYES | 2019-07-18 |
20190216712 | Hair dye composition, preparation method, and application method thereof | 2019-07-18 |
20190216713 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | 2019-07-18 |
20190216714 | IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | 2019-07-18 |
20190216715 | FUNCTIONALIZED TRANSITION METAL DICHALCOGENIDES AND COMPOSITION FOR ANTIOXIDATION CONTAINING THE SAME | 2019-07-18 |
20190216716 | TEA MASSAGE OIL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 2019-07-18 |
20190216717 | COMPOSITIONS COMPRISING DEAD SEA WATER AND POLYSACCHARIDES AND USES THEREOF AS SKIN PROTECTANTS | 2019-07-18 |
20190216718 | COSMETIC COMPOSITION CONTAINING COMPLEX EXTRACT OF SARGASSUM HORNERI AND ENTEROMORPHA PROLIFERA | 2019-07-18 |
20190216719 | USES OF COFFEE PULP EXTRACT | 2019-07-18 |
20190216720 | METHODS AND COMPOSITIONS FOR TREATING MIGRAINE AND CONDITIONS ASSOCIATED WITH PAIN | 2019-07-18 |
20190216721 | TOPICAL PHARMACEUTICAL FORMULATION | 2019-07-18 |
20190216722 | METHODS TO TREAT HEART FAILURE | 2019-07-18 |
20190216723 | PROTEIN STABILIZING FACTORS | 2019-07-18 |
20190216724 | Shear-Thinning Therapeutic Composition, and Related Methods | 2019-07-18 |
20190216725 | DRUG DELIVERY SYSTEM FOR THE DELIVERY OF INTEGRASE INHIBITORS | 2019-07-18 |
20190216726 | Particles, Compositions and Methods for Ophthalmic and/or Other Applications | 2019-07-18 |
20190216727 | Punctal Plug With Active Agent | 2019-07-18 |
20190216728 | NERIDRONIC ACID AND OTHER BISPHOSPHONATES FOR TREATING COMPLEX REGIONAL PAIN SYNDROME AND OTHER DISEASES | 2019-07-18 |
20190216729 | Gastric Retention and Controlled Release Delivery System | 2019-07-18 |
20190216730 | PULMONARY DELIVERY OF MRNA TO NON-LUNG TARGET CELLS | 2019-07-18 |
20190216731 | PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES | 2019-07-18 |
20190216732 | QUICK RELEASE SOLENOID ASSEMBLY | 2019-07-18 |
20190216733 | COLD-PROCESSED SELF-EMULSIFYING HYDROALCOHOLIC GEL COMPOSITIONS AND METHODS | 2019-07-18 |
20190216734 | A Novel Method For Producing Low Viscous And Highly Concentrated Biopharmaceutical Drug Products In Liquid Formulation | 2019-07-18 |
20190216735 | LIPOSOMAL FORMULATIONS | 2019-07-18 |
20190216736 | SCALE UP SYNTHESIS OF SILICASOME NANOCARRIERS | 2019-07-18 |
20190216737 | PEDIATRIC FORMULATION | 2019-07-18 |
20190216738 | PIRFENIDONE-CONTAINING TABLET AND CAPSULE FORMULATION | 2019-07-18 |
20190216739 | Oral Dosing of GLP-1 Compounds | 2019-07-18 |
20190216740 | EXTENDED RELEASE PHARMACEUTICAL FORMULATION | 2019-07-18 |
20190216741 | FORMULATIONS OF CYSTEAMINE AND CYSTEAMINE DERIVATIVES | 2019-07-18 |
20190216742 | Metal Oxide Encapsulated Drug Compositions and Methods of Preparing the Same | 2019-07-18 |
20190216743 | METHODS AND SYSTEMS OF TESTING FORMATION SAMPLES USING A ROCK HYDROSTATIC COMPRESSION CHAMBER | 2019-07-18 |
20190216744 | Abiotic Anti-VEGF Nanoparticle | 2019-07-18 |
20190216745 | Formulations of a transdermal patch for pain management | 2019-07-18 |
20190216746 | OXYBUTYNIN-CONTAINING TRANSDERMAL ABSORPTION PREPARATION | 2019-07-18 |
20190216747 | PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI-INFLAMMATORY AGENTS | 2019-07-18 |
20190216748 | TOBACCO PRODUCTS | 2019-07-18 |
20190216749 | TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES | 2019-07-18 |
20190216750 | EPINEPHRINE SPRAY FORMULATIONS | 2019-07-18 |
20190216751 | Compositions and Methods for the Treatment and Prevention of Cancer | 2019-07-18 |
20190216752 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASE | 2019-07-18 |
20190216753 | N-METHYL-D-ASPARTATE RECEPTOR ALLOSTERIC MODULATORS AND METHODS FOR THEIR USE | 2019-07-18 |
20190216754 | COMBINATION OF A SELECTIVE HISTONE DEACETYLASE 3 (HDAC3) INHIBITOR AND AN IMMUNOTHERAPY AGENT FOR THE TREATMENT OF CANCER | 2019-07-18 |
20190216755 | Combination Therapies Using HDAC Inhibitors | 2019-07-18 |
20190216756 | ORGANIC ACIDS AS AGENTS TO DISSOLVE CALCIUM MINERALS IN PATHOLOGICAL CALCIFICATION AND USES THEREOF | 2019-07-18 |
20190216757 | Methods for Cancer and Immunotherapy Using Prodrugs of Glutamine Analogs | 2019-07-18 |
20190216758 | CANCER STARVATION THERAPY | 2019-07-18 |
20190216759 | TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES | 2019-07-18 |
20190216760 | COMPOSITION FOR USE IN TREATING ROTAVIRUS INFECTION | 2019-07-18 |
20190216761 | COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME | 2019-07-18 |
20190216762 | VEGETARIAN COMPOSITION CONTAINING UNSATURATED FATTY ACIDS | 2019-07-18 |
20190216763 | COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS IN THE TREATMENT OF NEOPLASMS | 2019-07-18 |
20190216764 | PHARMACEUTICAL COMPOSITION CONTAINING A CIS-DIAMINE PLATINUM THIONE COMPLEX | 2019-07-18 |
20190216765 | COMPOSITIONS AND METHODS OF TREATING FUNGAL INFECTIONS OF THE NAILS | 2019-07-18 |
20190216766 | Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep | 2019-07-18 |
20190216767 | TOPICAL THERAPY FOR THE TREATMENT OF SKIN KERATOSES USING NANOPARTICLES OF TAXANES | 2019-07-18 |
20190216768 | PREPARATIONS OF TAXANES FOR INTRAVENOUS ADMINISTRATION AND THE PREPARATION METHOD THEREOF | 2019-07-18 |
20190216769 | Topical Application of Delphinidin Compounds Treats Rosacea | 2019-07-18 |
20190216770 | PHARMACEUTICAL PREPARATIONS | 2019-07-18 |
20190216771 | COMPOSITIONS AND METHODS FOR CANCER THERAPY | 2019-07-18 |
20190216772 | Antioxidant-Containing Food Composition for Use in Enhancing Antiviral Immunity in Companion Animals | 2019-07-18 |
20190216773 | METHODS TO MOBILIZE PROGENITOR/STEM CELLS | 2019-07-18 |
20190216774 | TRPV4 ANTAGONISTS | 2019-07-18 |
20190216775 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | 2019-07-18 |
20190216776 | LISINOPRIL COMPOSITIONS WITH AN INGESTIBLE EVENT MARKER | 2019-07-18 |
20190216777 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | 2019-07-18 |
20190216778 | PYRROLIDONE CARBOXYLIC ACID (PCA) FOR OPHTHALMIC USE | 2019-07-18 |
20190216779 | USE OF NEUROKININ-1 ANTAGONISTS TO TREAT A VARIETY OF PRURITIC CONDITIONS | 2019-07-18 |
20190216780 | Use Of Carbamate Compound In Order To Preventatively Treat Headaches | 2019-07-18 |
20190216781 | METHODS FOR TREATING HETEROTOPIC OSSIFICATION | 2019-07-18 |
20190216782 | NOVEL SUBSTITUTED BICYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS | 2019-07-18 |
20190216783 | Veliparib in Combination With Carboplatin for the Treatment of Triple Negative Breast Cancer | 2019-07-18 |
20190216784 | PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF | 2019-07-18 |
20190216785 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | 2019-07-18 |
20190216786 | USE OF 2-{4-[(4-{[1-CYCLOPROPYL-3-TETRAHYDRO-2H-PYRAN-4-yl)-1H-PYRAZOL-4yl- ]OXY} PYRIDINE-2-yl)AMINO]PYRIDIN-2-yl}PROPAN-2-OL IN THE TREATMENT OF CANCER | 2019-07-18 |
20190216787 | PRODRUGS OF PHENOLIC TRPV1 AGONISTS IN COMBINATION WITH LOCAL ANESTHETICS AND VASOCONSTRICTORS FOR IMPROVED LOCAL ANESTHESIA | 2019-07-18 |
20190216788 | PHARMACEUTICAL SUSPENSION DOSAGE FORM OF BENZIMIDAZOLE COMPOUNDS AND PROCESS OF PREPARATION THEREOF | 2019-07-18 |
20190216789 | Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists | 2019-07-18 |
20190216790 | Methods for Treating Pruritis | 2019-07-18 |
20190216791 | FORMULATIONS OF PIMAVANSERIN | 2019-07-18 |
20190216792 | CDK1 INHIBITORS OF ACETYL CHRYSIN MANNICH BASE DERIVATIVES, SYNTHESIS AND USE THEREOF | 2019-07-18 |
20190216793 | COMPOSITIONS AND METHODS FOR TREATING NEGATIVE SYMPTOMS IN NON-SCHIZOPHRENIC PATIENTS | 2019-07-18 |
20190216794 | WASP-PROTECTING SMALL MOLECULES, COMPOSITIONS, METHODS AND USES THEREOF IN THE TREATMENT OF INNATE AND ACQUIRED IMMUNE-RELATED DISORDERS OR CONDITIONS | 2019-07-18 |
20190216795 | Predicting Optimal Chemotherapy For CRC | 2019-07-18 |
20190216796 | LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTS | 2019-07-18 |
20190216797 | Buprenorphine-wafer for drug substitution therapy | 2019-07-18 |
20190216798 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2019-07-18 |
20190216799 | Compositions For Affecting Weight Loss | 2019-07-18 |
20190216800 | DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION | 2019-07-18 |
20190216801 | DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION | 2019-07-18 |
20190216803 | METHODS OF TREATING DEPRESSION WITH VORTIOXETINE | 2019-07-18 |
20190216804 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS | 2019-07-18 |